Pages that link to "Q28379384"
Jump to navigation
Jump to search
The following pages link to The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein (Q28379384):
Displaying 37 items.
- Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed alpha-helix (Q27636960) (← links)
- Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets (Q28080558) (← links)
- Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action (Q28343624) (← links)
- Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans (Q28343929) (← links)
- Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans (Q28354724) (← links)
- Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR (Q28361576) (← links)
- Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome (Q28366062) (← links)
- Calcineurin governs thermotolerance and virulence of Cryptococcus gattii (Q30536858) (← links)
- Novel paradigms for drug discovery: computational multitarget screening (Q30662767) (← links)
- Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans (Q33651856) (← links)
- Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans (Q33673568) (← links)
- Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin (Q33978506) (← links)
- Signal transduction cascades regulating fungal development and virulence. (Q34010291) (← links)
- Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host (Q34055174) (← links)
- Calcineurin is essential for survival during membrane stress in Candida albicans (Q34085830) (← links)
- DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans. (Q34440643) (← links)
- Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei (Q34735206) (← links)
- Donor transmission of Cryptococcus neoformans presenting late after renal transplantation (Q35608463) (← links)
- In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods (Q36425093) (← links)
- Signaling cascades as drug targets in model and pathogenic fungi (Q37230044) (← links)
- In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients (Q37625139) (← links)
- Antifungal adjuvants: Preserving and extending the antifungal arsenal (Q37705308) (← links)
- In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus (Q37734474) (← links)
- Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands (Q38065993) (← links)
- Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach (Q38871364) (← links)
- Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans (Q39514274) (← links)
- Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens (Q40771289) (← links)
- FK506 and the role of immunophilins in nerve regeneration (Q41697821) (← links)
- Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. (Q41889615) (← links)
- Cryptococcal infection in non-HIV immunosuppressed patients - Three case reports in a nephrology setting. (Q41969837) (← links)
- Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus neoformans (Q47300999) (← links)
- New Horizons in Antifungal Therapy. (Q48149179) (← links)
- and Assessment of FK506 Analogs as Novel Antifungal Drug Candidates (Q57789682) (← links)
- FKBP Ligands-Where We Are and Where to Go? (Q60046468) (← links)
- Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice (Q74059983) (← links)
- Tacrolimus-induced Diabetic Ketoacidosis in a Polymyositis Patient Precipitated by Fluconazole: A Case Report and Review of the Literature (Q90153191) (← links)
- Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents (Q90183033) (← links)